There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
GLUT1 deficiency syndrome (GLUT1DS) is caused by impaired glucose transport into brain
and is effectively treated by means of a ketogenic diet. In clinical practice the
diagnosis of GLUT1DS often is challenging due to the increasing complexity of symptoms,
diagnostic cut-offs for hypoglycorrhachia and genetic heterogeneity. In terms of treatment
alternative ketogenic diets and their long-term side effects as well as novel compounds
such as alpha-lipoic acid and triheptanoin have raised a variety of issues. The current
diagnostic and therapeutic approach to GLUT1DS is discussed in this review in view
of these recent developments.